Viramune and Mucosal inflammation - a phase IV clinical study of FDA data

Summary:

Mucosal inflammation is found among people who take Viramune, especially for people who are male, 30-39 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Viramune and have Mucosal inflammation. It is created by eHealthMe based on reports of 11,012 people who have side effects when taking Viramune from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 13, 2022

11,012 people reported to have side effects when taking Viramune.
Among them, 17 people (0.15%) have Mucosal inflammation.


What is Viramune?

Viramune has active ingredients of nevirapine. It is often used in hiv infection. eHealthMe is studying from 11,069 Viramune users for its effectiveness, alternative drugs and more.

What is Mucosal inflammation?

Mucosal inflammation (infection of mucous membrane) is found to be associated with 1,555 drugs and 1,147 conditions by eHealthMe.

Number of Viramune and Mucosal inflammation reports submitted per year:

Could Viramune cause Mucosal inflammation?

Time on Viramune when people have Mucosal inflammation *:

  • < 1 month: 66.67 %
  • 1 - 6 months: 33.33 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Mucosal inflammation when taking Viramune *:

  • female: 35.29 %
  • male: 64.71 %

Age of people who have Mucosal inflammation when taking Viramune *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 12.5 %
  • 30-39: 37.5 %
  • 40-49: 18.75 %
  • 50-59: 31.25 %
  • 60+: 0.0 %

Common drugs people take besides Viramune *:

  1. Zerit: 4 people, 23.53%
  2. Epivir: 2 people, 11.76%
  3. Paxil: 2 people, 11.76%
  4. Viread: 2 people, 11.76%
  5. Clonazepam: 2 people, 11.76%
  6. Lipitor: 2 people, 11.76%
  7. Crixivan: 2 people, 11.76%
  8. Truvada: 2 people, 11.76%
  9. Norvir: 2 people, 11.76%
  10. Intelence: 1 person, 5.88%

Common side effects people have besides Mucosal inflammation *:

  1. Fever: 5 people, 29.41%
  2. Alanine Aminotransferase Increased: 5 people, 29.41%
  3. Aspartate Aminotransferase Increased: 5 people, 29.41%
  4. Cheilitis (infection of lips): 5 people, 29.41%
  5. Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 4 people, 23.53%
  6. Erythema Multiforme (a type of hypersensitivity reaction): 4 people, 23.53%
  7. Rash Macular (small, flat red spots): 4 people, 23.53%
  8. Rash Papular (redness with papule): 3 people, 17.65%
  9. Aphthous Stomatitis (mouth ulcer): 3 people, 17.65%
  10. Nausea And Vomiting: 3 people, 17.65%

Common conditions people have *:

  1. Testis Cancer (testes cancer): 1 person, 5.88%
  2. Haematopoietic Stem Cell Mobilisation: 1 person, 5.88%
  3. Acute Hiv Infection: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Viramune and have Mucosal inflammation?

Check whether Mucosal inflammation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Mucosal inflammation and when was it recovered:

Expand to all the drugs that have ingredients of nevirapine:

Alternative drugs to, pros and cons of Viramune:

Common Viramune side effects:

Browse all side effects of Viramune:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Mucosal inflammation treatments and more:

COVID vaccines that are related to Mucosal inflammation:

Common drugs associated with Mucosal inflammation:

All the drugs that are associated with Mucosal inflammation:

Common conditions associated with Mucosal inflammation:

All the conditions that are associated with Mucosal inflammation:

How the study uses the data?

The study uses data from the FDA. It is based on nevirapine (the active ingredients of Viramune) and Viramune (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: